Quantcast

Latest Parkinson's disease Stories

2014-02-11 08:33:38

StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells. These treatments are being studied with expertise by board certified MD's in the United States. LA JOLLA, Calif., Feb. 11, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases, today announced the newest therapy to assist patients...

2014-02-05 12:27:55

Mounting Evidence of Biological Similarities Inspires Funding Program to Advance Understanding of Two Most Common Brain Diseases CHICAGO, NEW YORK and TORONTO, Feb. 5, 2014 /PRNewswire-USNewswire/ -- As research unveils overlap in the biology -- in addition to long-noted shared clinical symptoms -- of Parkinson's and Alzheimer's diseases, three non-profit organizations are uniting to encourage further study into the similarities and differences between the two most common brain diseases,...

Genetic Makeup Determines Parkinson's Risk From Pesticide Use
2014-02-05 09:34:22

Rebekah Eliason for redOrbit.com – Your Universe Online In the past, studies have shown that pesticides can cause an increased risk for the development of Parkinson’s disease. Recently, UCLA researchers have discovered that amount of risk varies with a person’s individual genetic makeup. People with a specific genetic variant and are living in extreme pesticide-exposed areas have an increased likelihood of developing the disease by two- to six-fold. Previously, the UCLA team found...

2014-02-04 23:03:41

In-demand research study “Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management” worked out by GBI Research has been recently published by Market Publishers Ltd. According to the report, by 2019-end, the Parkinson’s disease therapeutics market value is poised to decline to close to USD 2.9 billion. London, UK (PRWEB) February 04, 2014 At present, the Parkinson’s disease (PD) therapeutics market is led by symptomatic...

2014-02-04 12:27:52

VALLEY VIEW, Ohio, Feb. 4, 2014 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office. The application covers a system and method of controlling Parkinson's therapy in response to motor symptoms. The allowed claims include a portable system for measuring, quantifying, and treating Parkinson's disease, based on a calculated severity of tremor, bradykinesia, rigidity, or dyskinesia. The claims also...

2014-01-29 13:07:05

A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease. These findings, which were made using an animal model of the disease, demonstrate that a single therapy could simultaneously repair the multiple types of neurological damage caused by Parkinson's, providing an overall benefit that has not been achieved in other approaches. "One of the central...

2014-01-29 12:28:20

Alliance Leverages Independent Nonprofit Strengths to Enrich Programs for Parkinson's Community NEW YORK, Jan. 29, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) is pleased to announce its support of the Alliance of Independent Regional Parkinson Organizations (AIRPO), a consortium recently formed with the shared goals of finding a cure for Parkinson's and supporting those who live with the disease. AIRPO encourages collaboration, leverages...

2014-01-29 12:27:59

NEW YORK, Jan. 29, 2014 /PRNewswire-USNewswire/ -- Research projects from three biopharmaceutical companies in the United States comprise the 2013 second half (2H 2013) of The Michael J. Fox Foundation for Parkinson's Research (MJFF) Partnering Program. Among the most promising in the MJFF portfolio, Partnering Program participants' research projects are presented directly to industry groups who may wish to invest in further development of the project. By connecting industry leaders...

2014-01-28 08:27:30

Young Artist, Despite Dystonia, Uses His Artistic Skills To Raise Money For Dystonia Research LAS VEGAS, Jan. 28, 2014 /PRNewswire/ -- Imagine a potentially debilitating neuromuscular disease that is relatively unknown, yet affects a half-million Americans of various ages, and, despite ongoing research, so far has no known cure. In addition, treatments are currently limited and carry significant side effects and risk. Would this qualify as a disease worthy of public awareness and...

Stalling Symptoms Of Parkinson's Disease Using Long-term Spinal Cord Stimulation
2014-01-24 11:11:58

Duke University Medical Center Researchers at Duke Medicine have shown that continuing spinal cord stimulation appears to produce improvements in symptoms of Parkinson's disease, and may protect critical neurons from injury or deterioration. The study, performed in rats, is published online Jan. 23, 2014, in the journal Scientific Reports. It builds on earlier findings from the Duke team that stimulating the spinal cord with electrical signals temporarily eased symptoms of the...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related